DON in Pediatric Cerebral Malaria

NCT05478720 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

152

Enrollment

UNKNOWN

Sponsor class

Conditions

Malaria, Cerebral

Interventions

DRUG: 6-diazo-5-oxo-L-norleucine (DON)
DRUG: Placebo
DRUG: 6-diazo-5-oxo-L-norleucine (DON)

Sponsor

Douglas Postels, MD, MS

Collaborators

[object Object]